The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium – Prostate Specific Membrane Antigen (Lu-PSMA)
Condition(s):Metastatic Castration Resistant Prostate Cancer (mCRPC)Last Updated:June 1, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Castration Resistant Prostate Cancer (mCRPC)Last Updated:June 1, 2023Terminated
Condition(s):Advanced Prostate CancerLast Updated:May 19, 2021Unknown status
Condition(s):Metastatic Breast CancerLast Updated:August 30, 2017Unknown status
Condition(s):Neurofibromatosis 1; Neurofibroma; Atypical Neurofibroma; Atypical Neurofibromatosis; Plexiform Neurofibroma; Von Recklinghausen DiseaseLast Updated:March 2, 2021Active, not recruiting
Condition(s):Cancer; Metabolic Disease; Aneurysm; Neurologic DisorderLast Updated:February 28, 2024Not yet recruiting
Condition(s):Breast CancerLast Updated:October 27, 2016Completed
Condition(s):Breast Cancer; MetastasesLast Updated:August 10, 2016Withdrawn
Condition(s):Traumatic InjuriesLast Updated:May 24, 2023Completed
Condition(s):Ataxia TelangiectasiaLast Updated:February 7, 2024Completed
Condition(s):Multiple MyelomaLast Updated:September 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.